Fujifilm Holdings Corp · TSE:4901
Fujifilm — Q1 FY2025 Earnings Presentation
33 slides from Fujifilm's earnings presentation, Aug 6, 2025
Slide 1: Earnings Presentation: Financial Results for Q1 FY2025
Earnings Presentation Financial Results for Q1 FY2025 August 6, 2025 FUJIFILM Holdings Corporation Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are m anage ment’s current assumptions and beliefs based on currently availabl
Slide 2: Agenda
Agenda Consolidated Financial Results for Q1 FY2025 (April to June 2025) Earnings Highlights and Key Topics 1 Teiichi Goto, President, Representative Director & CEO FUJIFILM Holdings Corporation Financial Results and Business Summary by Operating Segment 2 Masayuki Higuchi, Director & Corporate Vice
Slide 3: Earnings Highlights and Key Topics
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 Q1 Earnings Highlights and Key Topics 01 FUJIFILM Holdings Corporation 3
Slide 4: Consolidated Performance for Q1 FY2025
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Earnings Highlights for Q1 FY2025 Consolidated Performance for Q1 FY2025 (Exchange rates: ¥145/US$ | -¥11 YoY; ¥164/Euro | -¥4 YoY) Revenue Operating income Net income attributable to FUJIFILM Holdings Record high Record high ¥ 749.5 billion ➡
Slide 5: Key Topics for Q1 FY2025: Bio CDMO
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Key Topics for Q1 FY2025 Bio CDMO Signed long-term contracts / MOUs with major pharmaceutical companies for a total of approx. US$2 billion for the four units under the second-phase expansion in North Carolina, U.S. (planned to start operation
Slide 6: Key Topics for Q1 FY2025: Initiatives toward Sustainability
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Key Topics for Q1 FY2025 Initiatives toward Sustainability Through our advanced products and services, we aim to realize a sustainable society by contributing to the solving of key environment issues, such as ensuring the safety of products an
Slide 7: Financial Results and Business Summary by Operating Segment
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 Financial Results and Business Summary by Operating Segment 02 * From Q2 FY2024, the amounts shown for each item in this document have been rounded off to the nearest ¥100 million. As a result, there may be some discrepancies with fi
Slide 8: Financial Results for Q1 FY2025 (April to June 2025)
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Financial Results for Q1 FY2025 (April to June 2025) (Billions of yen) Q1 Impact of Constant- FY2024 FY2025 Change exchange rate currency basis Revenue 749.0 Record high 749.5 0.5 (33.0) 33.5 100.0% 100.0% +0.1% +4.5% Operating Income 62.2 Rec
Slide 9: Consolidated Revenue and Operating Income by Operating Segment
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Consolidated Revenue and Operating Income by Operating Segment (Billions of yen) Q1 Revenue FY2024 FY2025 Change Constant-currency basis * Healthcare 235.2 228.5 (6.7) (2.9%) 3.7 +1.6% * Electronics 103.1 102.1 (
Slide 10: Business Summary: Healthcare
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Business Summary: Healthcare Revenue and income （Billions of yen） Factors affecting revenue FY2024 FY2025 Change Constant- ◼ Medical Systems currency basis - Lower China demand for medical consumables Revenue 235
Slide 11: Business Summary: Electronics
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Business Summary: Electronics Revenue and income （Billions of yen） Factors affecting revenue FY2024 FY2025 Change Constant- ◼ Semiconductor Materials currency basis + Strong sales for advanced applications, inclu
Slide 12: Business Summary: Business Innovation
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Business Summary: Business Innovation Revenue and income （Billions of yen） Factors affecting revenue FY2024 FY2025 Change Constant- ◼ Business Innovation currency basis + Strong sales of DX solutions and services
Slide 13: Business Summary: Imaging
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Business Summary: Imaging Revenue and income （Billions of yen） Factors affecting revenue FY2024 FY2025 Change Constant- ◼ Consumer Imaging ＋Strong sales of instax instant photo systems currency basis Revenue 130.
Slide 14: Consolidated Cash Flow
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Consolidated Cash Flow Cash in Cash out (Billions of yen) FY2023 FY2024 FY2025 Adjusted free cash flow excluding business acquisitions 1,500 Q1 Q1 Q1 104.7 Net income 53.4 60.9 53.8 97.4 1,000 (Billions of yen) D
Slide 15: Financial Forecast for FY2025
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Financial Forecast for FY2025 03 * From Q2 FY2024, the amounts shown for each item in this document have been rounded off to the nearest ¥100 million. As a result, there may be some discrepancies from figures published in the past, and in some
Slide 16: Full-year Forecast for FY2025
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Full-year Forecast for FY2025 The impact of U.S. tariff policies has been newly incorporated into the forecasts, which are unchanged from the previous forecast (announced on May 8) (Billions of yen) FY2025 FY2025 FY2024 Change from Change from
Slide 17: Financial Forecast by Operating Segment
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Financial Forecast by Operating Segment The impact of U.S. tariff policies has been absorbed into the forecasts of each segment, and therefore there is no change to the previously announced forecast (Billions of yen) FY2025 FY2025 Change from
Slide 18: Impact of the U.S. Tariff Policy
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Impact of the U.S. Tariff Policy The Company has minimized the impact of the U.S. tariff policies by reorganizing the supply chain, making additional cost reductions and others and factored the impact into the forecasts for the fiscal year end
Slide 19: Appendices: Financial Results for Q1 FY2025
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Appendices: Financial Results for Q1 FY2025 04 * From Q2 FY2024, the amounts shown for each item in this document have been rounded off to the nearest ¥100 million. As a result, there may be some discrepancies from figures published in the pas
Slide 20: Q1 3 months Earnings
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 | 3 months Earnings (Billions of yen) Q1 Revenue FY2025 FY2024 Change Constant-currency basis * Healthcare 235.2 228.5 (6.7) (2.9%) 3.7 +1.6% Medical Systems 157.7 144.0 (13.7) (8.7%) (7.1) (4.5%) Bio CDMO 47.1 53.2 6.0 +12.8% 8.9 +18.9% LS
Slide 21: Quarterly Earnings
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Quarterly Earnings (Billions of yen) FY2024 FY2025 Revenue Q1 Q2 Q3 Q4 Q1 * Healthcare 235.2 249.0 247.1 316.5 228.5 Medical Systems 157.7 166.9 162.6 206.1 144.0 Bio CDMO 47.1 48.1 51.3 73.0 53.2 LS Solutions 30.4 34.1 33.2 37.4 31.3 * Electr
Slide 22: Consolidated Revenue by Geographical Area
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Consolidated Revenue by Geographical Area (Billions of yen) FY2024 Q1 FY2025 Q1 Change Ratio (%) Ratio (%) Japan 31.9% 239.1 34.3% 256.9 17.8 +7.4% The Americas 20.8% 155.5 20.7% 155.3 (0.2) (0.1%) Europe 17.9% 133.8 16.6% 124.6 (9.3) (6.9%) C
Slide 23: Operating Income Analysis (Q1 YoY)
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Operating Income Analysis (Q1 YoY) (Billions of yen) Q1 (a) (b) FY2024 FY2025 Operation Raw Material （b-a) Operating Change FX FY2024 FY2025 Detail Actual Actual and others price One-time cost Segment Q1 Q1 * Healthcare 3.5 4.3 0.7 (0.5) (2.2)
Slide 24: Full-year Forecast for FY2025 Revenue by Business
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Full-year Forecast for FY2025 Revenue by Business (Billions of yen) FY2024 FY2025 FY2025 Change from Change from Actual Previous forecast Revised forecast previous year previous forecast (as of May 8, 2025) (as of Aug. 6, 2025) * Healthcare 1,
Slide 25: Operating Income Analysis (FY2025 Forecast vs Previous Forecast)
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Operating Income Analysis (FY2025 Forecast vs Previous Forecast) (Billions of yen) Previous Revised (a) (b) forecast forecast Operation Raw Material （b-a) Operating Change FX tariff Previous Revised Segment Detail (May 8,2025) (Aug.6,2025) and
Slide 26: Bio CDMO Profitability
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Bio CDMO Profitability (Q1 YoY; FY2025 Forecast vs FY2024 Results) EBITDA margin in Q1, excluding one-time costs, was in the low-teens percentage range, impacted by higher fixed costs in conjunction with the start of large-scale facilities For
Slide 27: Consolidated Balance Sheets
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Q1 FY2025 (April to June 2025) Consolidated Balance Sheets (Billions of yen) Change from Change from Mar. 2024 Mar. 2025 June 2025 Mar. 2024 Mar. 2025 June 2025 Mar. 2025 Mar. 2025 Cash and cash equivalents 179.7 172.1 160.0 (12.1) Short-term
Slide 28: Capital Expenditure and Depreciation & Amortization
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Capital Expenditure and Depreciation & Amortization Capital Expenditure and Depreciation & Amortization Q1 Full Year (Billions of yen) 6,000 600.0 FY2025 FY2024 FY2025 FY2024 Forecast 532.1 Healthcare 101.3 105.3 449.2 339.0 Electronics 8.4 4.
Slide 29: R&D Expenses and SG&A Expenses
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices R&D Expenses and SG&A Expenses (Billions of yen) R&D Expenses and SG&A Expenses Ratio to revenue 9,000 900.0 40.0% (Billions of yen) 806.5 Q1 Full Year 752.5 FY2025 30.0% FY2024 FY2025 FY2023 Forecast 600.0 6,000 Healthcare 14.9 14.8 61.3 25.5
Slide 30: Market Trend and Number of Employees
Earnings Highlights Q1 FY2025 FY2025 Forecast Appendices Market Trend and Number of Employees ▐ Exchange rates (average) / Raw material prices (average) FY2024 FY2025 Unit Q1 Q2 Q3 Q4 Full Year Q1 Q2-4 Full Year US$ ¥/US$ 156 149 152 152 152 145 145 145 € ¥/€ 168 164 163 161 164 164 155 157 Silver 1
Slide 31: References
Earnings Highlights FY2024 FY2025 Forecast Appendices References ▍ FUJIFILM Holdings - Investor Relations https://ir.fujifilm.com/en/investors.html ▍ FUJIFILM Holdings Integrated Report https://ir.fujifilm.com/en/investors/ir-materials/integrated-report.html ▍ IR Materials https://ir.fujifilm.com/en
Slide 32: FUJIFILM Holdings Corporation
FUJIFILM Holdings Corporation
Slide 33: FUJIFILM: Value from Innovation
FUJIFILM Value from Innovation